BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 32652079)

  • 1. Virtual Screening of Human Class-A GPCRs Using Ligand Profiles Built on Multiple Ligand-Receptor Interactions.
    Chan WKB; Zhang Y
    J Mol Biol; 2020 Aug; 432(17):4872-4890. PubMed ID: 32652079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FINDSITE(comb): a threading/structure-based, proteomic-scale virtual ligand screening approach.
    Zhou H; Skolnick J
    J Chem Inf Model; 2013 Jan; 53(1):230-40. PubMed ID: 23240691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PoLi: A Virtual Screening Pipeline Based on Template Pocket and Ligand Similarity.
    Roy A; Srinivasan B; Skolnick J
    J Chem Inf Model; 2015 Aug; 55(8):1757-70. PubMed ID: 26225536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You?
    Ballante F; Kooistra AJ; Kampen S; de Graaf C; Carlsson J
    Pharmacol Rev; 2021 Oct; 73(4):527-565. PubMed ID: 34907092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Receptor-ligand docking simulation for membrane proteins].
    Hirokawa T
    Yakugaku Zasshi; 2007 Jan; 127(1):123-31. PubMed ID: 17202792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A benchmarking study on virtual ligand screening against homology models of human GPCRs.
    Lim VJY; Du W; Chen YZ; Fan H
    Proteins; 2018 Sep; 86(9):978-989. PubMed ID: 30051928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
    PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docking and Virtual Screening Strategies for GPCR Drug Discovery.
    Beuming T; Lenselink B; Pala D; McRobb F; Repasky M; Sherman W
    Methods Mol Biol; 2015; 1335():251-76. PubMed ID: 26260606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS; Saxena AK
    Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing GPCR homology models constructed from templates of various transmembrane sequence identities: Binding mode prediction and docking enrichment.
    Loo JSE; Emtage AL; Ng KW; Yong ASJ; Doughty SW
    J Mol Graph Model; 2018 Mar; 80():38-47. PubMed ID: 29306746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galaxy7TM: flexible GPCR-ligand docking by structure refinement.
    Lee GR; Seok C
    Nucleic Acids Res; 2016 Jul; 44(W1):W502-6. PubMed ID: 27131365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of virtual screening against GPCR homology models: Impact of template selection and treatment of binding site plasticity.
    Jaiteh M; Rodríguez-Espigares I; Selent J; Carlsson J
    PLoS Comput Biol; 2020 Mar; 16(3):e1007680. PubMed ID: 32168319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H; Fu W; Wang Z; Wang X; Lei T; Zhu F; Li D; Chang S; Xu L; Hou T
    ACS Chem Neurosci; 2019 Jan; 10(1):677-689. PubMed ID: 30265513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From three-dimensional GPCR structure to rational ligand discovery.
    Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
    Adv Exp Med Biol; 2014; 796():129-57. PubMed ID: 24158804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended template-based modeling and evaluation method using consensus of binding mode of GPCRs for virtual screening.
    Sato M; Hirokawa T
    J Chem Inf Model; 2014 Nov; 54(11):3153-61. PubMed ID: 25350693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in GPCR modeling evaluated by the GPCR Dock 2013 assessment: meeting new challenges.
    Kufareva I; Katritch V; ; Stevens RC; Abagyan R
    Structure; 2014 Aug; 22(8):1120-1139. PubMed ID: 25066135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.
    Kooistra AJ; Kuhne S; de Esch IJ; Leurs R; de Graaf C
    Br J Pharmacol; 2013 Sep; 170(1):101-26. PubMed ID: 23713847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benchmarking the performance of MM/PBSA in virtual screening enrichment using the GPCR-Bench dataset.
    Yau MQ; Emtage AL; Loo JSE
    J Comput Aided Mol Des; 2020 Nov; 34(11):1133-1145. PubMed ID: 32851579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Metadynamics-Based Protocol for the Determination of GPCR-Ligand Binding Modes.
    Söldner CA; Horn AHC; Sticht H
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Hybrid Approach to Structure and Function Modeling of G Protein-Coupled Receptors.
    Latek D; Bajda M; Filipek S
    J Chem Inf Model; 2016 Apr; 56(4):630-41. PubMed ID: 26978043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.